Your session is about to expire
← Back to Search
Platelet Rich Plasma
PRP Group for Pressure Sore
N/A
Waitlist Available
Led By Louis Thibodeaux, MD,FACCWS
Research Sponsored by ACR Biologics, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 weeks
Awards & highlights
Study Summary
This trial will test whether autologous platelet rich plasma (PRP) can speed up the healing of chronic wounds.
Eligible Conditions
- Pressure Sore
- Foot Ulcer
- Venous Ulcers
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 20 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Wound Closure
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: PRP GroupActive Control1 Intervention
Patients will receive weekly PRP treatments
Group II: Standard of CarePlacebo Group1 Intervention
Patients will receive weekly standard of care.
Find a Location
Who is running the clinical trial?
ACR Biologics, LLCLead Sponsor
Louis Thibodeaux, MD,FACCWSPrincipal InvestigatorTriHealth Hatton Research Institute | Bethesda North Hospital
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger